<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000112'>Nephropathy</z:hpo> of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (NAPS) is an increasingly well-recognized aspect of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The most characteristic histopathology is that of <z:e sem="disease" ids="C0034155" disease_type="Disease or Syndrome" abbrv="">thrombotic microangiopathy</z:e>, and <z:mp ids='MP_0005048'>thrombosis</z:mp> occurring in the renal vasculature is thought to be the initiating event </plain></SENT>
<SENT sid="2" pm="."><plain>Other less common pathologies have been reported, and the mechanisms of these are unclear </plain></SENT>
<SENT sid="3" pm="."><plain>Therapy has been largely empiric </plain></SENT>
<SENT sid="4" pm="."><plain>We report a case of NAPS in a patient with atypical pathology, who has declined therapy with <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> and <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> and who has maintained <z:mpath ids='MPATH_458'>normal</z:mpath> renal function in 20 years of follow-up </plain></SENT>
</text></document>